NCT01828086 Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis Status COMPLETED Phase PHASE1
NCT01826214 Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia Status COMPLETED Phase PHASE2
NCT01825980 Proof of Concept Study to Determine the Safety and Antiviral Effect of BZF961 With or Without Ritonavir Boosting in Hepatitis C Virus Infected Patients Status COMPLETED Phase PHASE1/PHASE2
NCT01824264 Dose-finding Study of LIK066 Compared With Placebo or Sitagliptin to Evaluate Change in HbA1c in Patients With Diabetes Status WITHDRAWN Phase PHASE2
NCT01822613 Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC) Status COMPLETED Phase PHASE1
NCT01820325 Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer Status TERMINATED Phase PHASE1
NCT01819389 Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment Intolerance Status COMPLETED Phase PHASE3
NCT01818726 Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients Status TERMINATED Phase PHASE4
NCT01816594 NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer Status COMPLETED Phase PHASE2
NCT01816256 Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms Status COMPLETED Phase NA
NCT01813019 Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy Status TERMINATED Phase PHASE2
NCT01811485 Study of Efficacy and Safety LMF237 in Patients With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Vildagliptin Monotherapy Status COMPLETED Phase PHASE3
NCT01811472 Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients Status COMPLETED Phase PHASE2
NCT01807520 Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Nail Psoriasis Status COMPLETED Phase PHASE3
NCT01806597 Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis Status COMPLETED Phase PHASE3
NCT01804400 A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber Status COMPLETED Phase PHASE2
NCT01802879 Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Continue to Benefit From the Treatment as Judged by the Investigator Status COMPLETED Phase PHASE2
NCT01801917 Efficacy and Tolerability of BAF312 in Patients With Polymyositis Status TERMINATED Phase PHASE2
NCT01801280 Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS Status COMPLETED Phase PHASE4
NCT01794780 A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator Status COMPLETED Phase PHASE4